An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer-Reference-Cited by-同舟云学术

An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer

Published:2009-01 Issue:4 Volume:48 Page:522-531
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Henriksen Katrine L.,Rasmussen Birgitte B.,Lykkesfeldt Anne E.,Møller Susanne,Ejlertsen Bent,Mouridsen Henning T.

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/02841860802676383

Reference26 articles.

1. Tamoxifen in advanced breast cancer

2. Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype

3. Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

4. Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

5. Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of progranulin (PGRN) in the pathogenesis and prognosis of breast cancer;Cytokine;2022-03

2. Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives;Obesity Reviews;2021-09-24

3. Expression of SCUBE2 and BCL2 Predicts Favorable Response in ERα Positive Breast Cancer;ARCH IRAN MED;2021

4. A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis;Acta Oncologica;2017-05-10

5. Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells;BMC Cancer;2016-07-16